• Search
  • Helpdesk
  • Sales contact

Immunology Case Study

Last updated : May 6, 2025

Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study duration can be very long whilst patients are in pain.

To overcome these challenges, Kayentis offers strong and global experience in immuno-inflammation trials, especially with:

  • experienced teams and a powerful solution to face eCOA complexities,
  • adapted options to support site staff,
  • and additional features for the comfort of the patient

Therefore, Kayentis contributes to the success and quality of immunology clinical trials.

Learn more in the case study 👇

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

5th Annual Clinical Trial Innovation Summit

JUNE 26, 2025 • Basel, CH
Clinical Trial Innovation Summit 2025 | June 26, 2025

The reckless value of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

SCDM 2025

Baltimore, Maryland, USA - 27-30 SEPT 2025
Annual Conference 2025 – SCDMLive    

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain